Amanote Research
Register
Sign In
Possible FDA-approved Drugs to Treat Ebola Virus Infection
Infectious Diseases of Poverty
- United Kingdom
doi 10.1186/s40249-015-0055-z
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Environmental
Public Health
Infectious Diseases
Occupational Health
Date
May 4, 2015
Authors
Shu Yuan
Publisher
Springer Science and Business Media LLC
Related search
Repurposing FDA-approved Drugs as Therapeutics to Treat Rift Valley Fever Virus Infection
Frontiers in Microbiology
Microbiology
Identification of FDA-approved Drugs That Computationally Bind to MDM2
Chemical Biology and Drug Design
Biochemistry
Organic Chemistry
Drug Discovery
Molecular Medicine
Pharmacology
Repurposing FDA-approved Drugs for Anti-Aging Therapies
Biogerontology
Aging
Gerontology
Geriatrics
Identification of FDA Approved Drugs Targeting COVID-19 Virus by Structure-Based Drug Repositioning
A Review on the Drugs Approved by US-FDA and DCGI
TEXILA INTERNATIONAL JOURNAL OF CLINICAL RESEARCH
Quantitative Analysis on the Characteristics of Targets With FDA Approved Drugs
International Journal of Biological Sciences
Applied Microbiology
Evolution
Ecology
Developmental Biology
Cell Biology
Molecular Biology
Systematics
Behavior
Biotechnology
New Role for FDA-Approved Drugs in Combating Antibiotic-Resistant Bacteria
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
FDA-Approved Biosimilar Insulin
Journal of diabetes science and technology
Internal Medicine
Endocrinology
Bioengineering
Biomedical Engineering
Metabolism
Diabetes
Drug Development Process and Novel Drugs Approved by FDA for 2017 -18
Applied Clinical Research, Clinical Trials and Regulatory Affairs